Law, History & ReformReferenceAll articles

OECD Test Guideline 409

OECD Test Guideline 409, published in 1998, governs 90-day repeated dose oral toxicity testing in non-rodents. It directly states that the 'commonly used non-rodent species is the dog' and that 'beagles are frequently used.' The guideline specifies a minimum of 4 animals per sex per group, yielding a basic study design of 32+ dogs, with terminal necropsy as the endpoint. It is the single most important document embedding beagles into global regulatory practice.

Based on: OECD TG 409, ICH M3(R2)

Overview

OECD Test Guideline 409, "Repeated Dose 90-Day Oral Toxicity Study in Non-Rodents," was published in 1998. It is one of a suite of test guidelines issued by the Organisation for Economic Co-operation and Development that form the backbone of international chemical and pharmaceutical safety testing. TG 409 is the guideline that most directly embeds beagles into regulatory practice worldwide.

The Key Language

The guideline states that the "commonly used non-rodent species is the dog" and that "beagles are frequently used." This language does not mandate beagles by name in the way a statute would. Instead, it creates a regulatory default — a convention so widely followed that deviating from it requires justification that regulators may not accept.

Study Design

TG 409 specifies a minimum study structure.

  • Animals per group — At least 4 per sex per dose group
  • Dose groups — Typically 3 dose levels plus a control group
  • Minimum total — 4 animals x 2 sexes x 4 groups = 32 dogs at minimum
  • Duration — 90 consecutive days of dosing
  • Recovery group — Optional satellite groups may add 8-16 additional animals

In practice, studies often exceed the minimum. Recovery groups, additional dose levels, and replacement animals can push a single study to 40-50 dogs.

What Is Measured

The guideline requires comprehensive data collection throughout the study and at termination.

  • Clinical observation — Daily monitoring for signs of toxicity, behavioral changes, morbidity
  • Body weight and food consumption — Recorded at regular intervals
  • Clinical pathology — Blood chemistry, hematology, and urinalysis
  • Terminal necropsy — Full post-mortem examination including organ weights, gross pathology, and histopathology of specified tissues

The terminal necropsy is the critical element. It is the reason the study endpoint is death. The data regulators require — organ weights, tissue sections, microscopic pathology — can only be obtained from euthanized animals.

Global Adoption

OECD test guidelines are not binding law in themselves. They become binding when adopted by member countries' regulatory agencies. TG 409 has been adopted or referenced by the FDA, EMA, Japanese PMDA, and dozens of other national regulators. The mutual acceptance of data under OECD agreements means a study conducted to TG 409 in one country is accepted by regulators in all member countries.

Significance

TG 409 is the document that answers the question "why beagles?" at the regulatory level. Not because beagles are uniquely suited — minipigs and other species can serve as non-rodents — but because the guideline names dogs, convention specifies beagles, and the global regulatory system runs on convention.

Sources

  1. 1.OECD TG 409, 1998. Repeated Dose 90-Day Oral Toxicity Study in Non-Rodents.
  2. 2.ICH M3(R2), 2009. Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials.